dc.contributor.author |
Jadhav, Sanjay |
|
dc.contributor.author |
Nalawade, Harshada |
|
dc.date.accessioned |
2021-10-14T09:11:42Z |
|
dc.date.available |
2021-10-14T09:11:42Z |
|
dc.date.issued |
2021-09 |
|
dc.identifier.citation |
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive |
en_US |
dc.identifier.issn |
2581-9879 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/123456789/9975 |
|
dc.description.abstract |
Actually IP waiver was initiated with a proposal by India and South Africa at WTO at last year October 8.It was for a waiver on all covid-19 invention including testing as well as diagnostics under the conditions of trips agreement. Now it will take to remove intellectual property rights for vaccines should result in universal response to the current pandemic situation and way to tackle coming new variants of covid-19.Patent waiver on vaccines may create a barrier to share information for others for production of vaccines. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Kesari Mahratta Trust |
en_US |
dc.subject |
COVID-19 |
en_US |
dc.subject |
Corona virus Pandemic |
en_US |
dc.subject |
Patent waiver |
en_US |
dc.title |
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive |
en_US |
dc.type |
Article |
en_US |